scholarly journals COPING STYLE OF PARENTS OF PEDIATRIC CANCER PATIENTS AT A HOSPITAL A LIMA

2021 ◽  
Vol 10 (6) ◽  
pp. 3777-3780
Author(s):  
Perez-Siguas Rosa
Keyword(s):  
Family Member ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Coping Style ◽  
High Capacity ◽  
Care Program ◽  
Stressful Situation ◽  
Coping Capacity ◽  
Pediatric Cancer Patients ◽  
Study Participants

The coping that parents present with their child with cancer, they tend to differentiate and adapt during the situations that their child presents during each stage of treatment. The objective is to determine the Coping Style of parents of pediatric cancer patients at a Hospital in Lima. In the results, 1.2% of the study participants (2/168) have a medium coping capacity, while the majority, equivalent to 98.8% (166/168), have a high capacity of coping. It is concluded that a comprehensive care program should be accessed where it allows to elevate the areas affected by the stressful situation during the disease and by the aspects involved in having a family member with cancer.

scholarly journals Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital

2019 ◽  
Author(s):  
Husnia Bedewi ◽  
Malede Berihun ◽  
Atalay Mulu ◽  
Tamrat Assefa
Keyword(s):  
Febrile Neutropenia ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Management Practice ◽  
Tertiary Care ◽  
Tikur Anbessa Specialized Hospital ◽  
Definitive Therapy ◽  
Pediatric Cancer Patients ◽  
Culture And Sensitivity ◽  
Study Participants

Abstract Objective This study aimed at assessing the management practice of febrile neutropenia (FN) in pediatric cancer patients at Tikur Anbessa Specialized Hospital (TASH), Ethiopia by reviewing patients’ charts from 135 participants retrospectively. Data was entered into Epi-info 7 and exported to SPSS 20 for analysis. Results Empiric antibiotics therapy (EAT) was given to all patients in which ceftriaxone with gentamycin constituted of 71.9% followed by ceftriaxone monotherapy. EATs were converted to others in 20 (14.8%) and 2(1.5%) patients for the first and second times respectively, mainly based on poor clinical response without conducting culture and sensitivity tests. These tests were done only for 13 (9.6%) participants and growth was seen in 5 patients; and definitive therapy was given for 2 patients. ANC value was above 500 cell/mm3 in 80.7% of patients and 98.5% of study participants were afebrile after completion FN treatment. Most of them (70.4%) were treated for FN and 7 of patients died due to all case mortality. The hospital should not rely mainly only on ceftriaxone with gentamycin as EAT and also should do culture and sensitivity test to optimize therapy based on susceptibility result before conversion and modification of therapy in management of FN.

scholarly journals Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital

2019 ◽  
Author(s):  
Husnia Bedewi ◽  
Malede Berihun ◽  
Atalay Mulu ◽  
Tamrat Assefa
Keyword(s):  
Febrile Neutropenia ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Management Practice ◽  
Tertiary Care ◽  
Tikur Anbessa Specialized Hospital ◽  
Definitive Therapy ◽  
Pediatric Cancer Patients ◽  
Culture And Sensitivity ◽  
Study Participants

Abstract Objective This study aimed at assessing the management practice of febrile neutropenia (FN) in pediatric cancer patients at Tikur Anbessa Specialized Hospital (TASH), Ethiopia by reviewing patients’ charts from 135 participants retrospectively. Data was entered into Epi-info 7 and exported to SPSS 20 for analysis. Results Empiric antibiotics therapy (EAT) was given to all patients in which ceftriaxone with gentamycin constituted of 71.9% followed by ceftriaxone monotherapy. EATs were converted to others in 20 (14.8%) and 2(1.5%) patients for the first and second times respectively, mainly based on poor clinical response without conducting culture and sensitivity tests. These tests were done only for 13 (9.6%) participants and growth was seen in 5 patients; and definitive therapy was given for 2 patients. ANC value was above 500 cell/mm3 in 80.7% of patients and 98.5% of study participants were afebrile after completion FN treatment. Most of them (70.4%) were treated for FN and 7 of patients died due to all case mortality. The hospital should not rely mainly only on ceftriaxone with gentamycin as EAT and also should do culture and sensitivity test to optimize therapy based on susceptibility result before conversion and modification of therapy in management of FN.

scholarly journals Febrile neutropenia management in pediatric cancer patients at Ethiopian Tertiary Care Teaching Hospital

2019 ◽  
Author(s):  
Husnia Bedewi ◽  
Malede Berihun ◽  
Atalay Mulu ◽  
Tamrat Assefa
Keyword(s):  
Febrile Neutropenia ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Management Practice ◽  
Tertiary Care ◽  
Tikur Anbessa Specialized Hospital ◽  
Definitive Therapy ◽  
Pediatric Cancer Patients ◽  
Culture And Sensitivity ◽  
Study Participants

Abstract Objective This study aimed at assessing the management practice of febrile neutropenia (FN) in pediatric cancer patients at Tikur Anbessa Specialized Hospital (TASH), Ethiopia by reviewing patients’ charts from 135 participants retrospectively. Data was entered into Epi-info 7 and exported to SPSS 20 for analysis. Results Empiric antibiotics therapy (EAT) was given to all patients in which ceftriaxone with gentamycin constituted of 71.9% followed by ceftriaxone monotherapy. EATs were converted to others in 20 (14.8%) and 2(1.5%) patients for the first and second times respectively, mainly based on poor clinical response without conducting culture and sensitivity tests. These tests were done only for 13 (9.6%) participants and growth was seen in 5 patients; and definitive therapy was given for 2 patients. ANC value was above 500 cell/mm3 in 80.7% of patients and 98.5% of study participants were afebrile after completion FN treatment. Most of them (70.4%) were treated for FN and 7 of patients died due to all case mortality. The hospital should not rely mainly only on ceftriaxone with gentamycin as EAT and also should do culture and sensitivity test to optimize therapy based on susceptibility result before conversion and modification of therapy in management of FN.

Quality of life in school-age pediatric cancer patients

2013 ◽  
Author(s):  
Fransisca M. Sidabutar ◽  
Anggie Regia Anandari ◽  
Ingrid Karli ◽  
Yusnita Katagori ◽  
Henny E. Wirawan
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
School Age ◽  
Pediatric Cancer Patients

Psychosocial Needs of Pediatric Cancer Patients in the Bronx

2007 ◽  
Author(s):  
Margaret M. Mannix ◽  
Nicole Furnari ◽  
Adam Rudolph ◽  
Karen M. Moody
Keyword(s):  
Cancer Patients ◽  
Pediatric Cancer ◽  
Psychosocial Needs ◽  
Pediatric Cancer Patients

Use of virtual reality as a distractor for painful procedures in pediatric cancer patients

2001 ◽  
Author(s):  
Barbara O. Rothbaum ◽  
Larry F. Hodges ◽  
Jonathan Gershon ◽  
Michael Briones ◽  
Melissa Pickering
Keyword(s):  
Virtual Reality ◽  
Cancer Patients ◽  
Pediatric Cancer ◽  
Pediatric Cancer Patients

PO22 Honey reduces chemoradiotherapy-induced mucositis in pediatric cancer patients

2012 ◽  
Vol 82 ◽  
pp. S17 ◽  
Author(s):  
S. Al Jaouni ◽  
A. Hussein ◽  
M. Al Muhayawi ◽  
K. Ibrahim ◽  
I. Elfiki
Keyword(s):  
Cancer Patients ◽  
Pediatric Cancer ◽  
Pediatric Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document